Charnley low-friction arthroplasty in rheumatoid patients: A survival study up to 20 years

Abstract

The survivorship of 1,553 consecutive Charnley low-friction arthroplasties (LFA) in 1,086 patients with rheumatoid arthritis (RA) were analyzed. There were 846 women (1,236 hips) and 240 men (317 hips), with a mean age of 53.1 years (range, 24–77 years; standard deviation, 10.7). A uniform postoperative regimen with protected weight bearing for 2 months (6 months in patients with bone grafting on the acetabular side) was used throughout the whole study. The overall survival with revision as the endpoint was 90.5% (95% confidence interval [CI], 88.7–92.2) at 10 years and 83% (95% CI, 80.3–85.7) at 15 years. The survival of the femoral component was 93.2% (95% CI, 91.8–96.7) and 89.9% (95% CI, 88.0–93.0) at 10 and 15 years, and survival of the acetabulum was 93.6% (95% CI, 92.1–95.1) and 87.1% (95% CI, 84.6–89.5) at 10 and 15 years. The indication for revision was late deep infection in 19 patients (1.2%) and in others aseptic loosening of prosthetic components. Young age, male sex, and secondary reactive amyloidosis impaired significantly the survival of LFA in the RA patients. In all, cemented LFA provided good results, and it can be justified for the treatment of hip destruction in RA.